Published in Dev Med Child Neurol on November 01, 2000
Neurocognitive status in long-term survivors of childhood CNS malignancies: a report from the Childhood Cancer Survivor Study. Neuropsychology (2009) 2.29
Neurocognitive function after radiotherapy for paediatric brain tumours. Nat Rev Neurol (2012) 1.19
Neurodevelopmental impact on children treated for medulloblastoma: a review and proposed conceptual model. Dev Disabil Res Rev (2008) 1.00
Neurogenesis, exercise, and cognitive late effects of pediatric radiotherapy. Neural Plast (2013) 0.92
Cerebral white matter integrity and executive function in adult survivors of childhood medulloblastoma. Neuro Oncol (2012) 0.87
Working memory abilities among children treated for medulloblastoma: parent report and child performance. J Pediatr Psychol (2014) 0.82
Regional white matter anisotropy and reading ability in patients treated for pediatric embryonal tumors. Brain Imaging Behav (2010) 0.81
Impairment of intellectual functions after surgery and posterior fossa irradiation in children with ependymoma is related to age and neurologic complications. BMC Cancer (2008) 0.81
Survivors of pediatric posterior fossa tumors: cognitive outcome, intervention, and risk-based care. Eur J Oncol Nurs (2008) 0.81
A systematic review of neuropsychological outcomes following posterior fossa tumor surgery in children. Childs Nerv Syst (2015) 0.76
Attention, processing speed, and executive functioning in pediatric brain tumor survivors treated with proton beam radiation therapy. Radiother Oncol (2017) 0.75
Standard-risk medulloblastoma treated by adjuvant chemotherapy followed by reduced-dose craniospinal radiation therapy: a French Society of Pediatric Oncology Study. J Clin Oncol (2005) 1.70
Genome search for susceptibility loci of common idiopathic generalised epilepsies. Hum Mol Genet (2000) 1.61
Postoperative chemotherapy without irradiation for ependymoma in children under 5 years of age: a multicenter trial of the French Society of Pediatric Oncology. J Clin Oncol (2001) 1.48
Dural sinus thrombosis in children with cancer. Med Pediatr Oncol (1997) 1.45
Long-term intellectual outcome in children with posterior fossa tumors according to radiation doses and volumes. Int J Radiat Oncol Biol Phys (1999) 1.40
[Determinations of urine protein concentration and plasma replacement therapy]. Ann Biol Clin (Paris) (1999) 1.39
Papillomas and carcinomas of the choroid plexus in children. J Neurosurg (1998) 1.34
Is there a place for radiation therapy in the management of hepatoblastomas and hepatocellular carcinomas in children? Int J Radiat Oncol Biol Phys (1992) 1.34
Osteosarcoma recurrences in pediatric patients previously treated with intensive chemotherapy. J Clin Oncol (1994) 1.32
Radiation-induced cerebral vasculopathy in children with neurofibromatosis and optic pathway glioma. Ann Neurol (1999) 1.29
The right brain hemisphere is dominant in human infants. Brain (1997) 1.27
Loss of heterozygosity of the RB gene is a poor prognostic factor in patients with osteosarcoma. J Clin Oncol (1996) 1.26
Choroid plexus carcinomas in childhood: clinical features and prognostic factors. Neurosurgery (1998) 1.17
Musculoskeletal tumors: follow-up with MR imaging after treatment with surgery and radiation therapy. Radiology (1987) 1.15
Topotecan as a radiosensitizer in the treatment of children with malignant diffuse brainstem gliomas: results of a French Society of Paediatric Oncology Phase II Study. Cancer (2005) 1.12
Purification and Characterization of Conjugated Bile Salt Hydrolase from Bifidobacterium longum BB536. Appl Environ Microbiol (1995) 1.11
Growth and endocrine disorders in optic glioma. Eur J Pediatr (1990) 1.11
Combined treatment modality for intracranial germinomas: results of a multicentre SFOP experience. Société Française d'Oncologie Pédiatrique. Br J Cancer (1999) 1.10
Design and results of the initial intervention program for the Lung Health Study. The Lung Health Study Research Group. Prev Med (1993) 1.08
Neuropsychiatric aspects of tuberous sclerosis. Ann N Y Acad Sci (1991) 1.08
When do children with optic pathway tumours need treatment? An oncological perspective in 106 patients treated in a single centre. Eur J Pediatr (2000) 1.08
Intracranial Ewing sarcoma/'peripheral' primitive neuroectodermal tumor of dural origin with molecular genetic confirmation. J Neurooncol (2001) 1.08
Treatment of intracranial ependymomas of children: review of a 15-year experience. Int J Radiat Oncol Biol Phys (1994) 1.07
Targeting of adenoviral vectors through a bispecific single-chain antibody. Cancer Gene Ther (2000) 1.06
Quality-of-life, mood and executive functioning after childhood craniopharyngioma treated with surgery and proton beam therapy. Brain Inj (2012) 1.05
Brief sexual inquiry in gynecologic practice. Obstet Gynecol (1989) 1.03
Radiotherapy followed by high dose busulfan and thiotepa: a prospective assessment of high dose chemotherapy in children with diffuse pontine gliomas. Cancer (2000) 1.03
Conditionally replicative adenovirus expressing a targeting adapter molecule exhibits enhanced oncolytic potency on CAR-deficient tumors. Gene Ther (2003) 1.02
Pulmonary evaluation of patients with osteosarcoma: roles of standard radiography, tomography, CT, scintigraphy, and tomoscintigraphy. AJR Am J Roentgenol (1984) 1.01
Outcome of flat bone sarcomas (other than Ewing's) in children and adolescents: a study of 25 cases. Br J Cancer (2004) 1.01
Hemorrhagic cystitis following high-dose chemotherapy and bone marrow transplantation in children with malignancies: incidence, clinical course, and outcome. J Clin Oncol (1989) 1.01
Outcome of radiation-related osteosarcoma after treatment of childhood and adolescent cancer: a study of 23 cases. J Clin Oncol (1999) 0.99
Treatment of high risk medulloblastomas in children above the age of 3 years: a SFOP study. Eur J Cancer (2006) 0.97
Nonmetastatic intracranial germinoma: the experience of the French Society of Pediatric Oncology. Cancer (1997) 0.97
Repeated high-dose chemotherapy followed by purged autologous bone marrow transplantation as consolidation therapy in metastatic neuroblastoma. J Clin Oncol (1987) 0.97
Carboplatin before and during radiation therapy for the treatment of malignant brain stem tumours: a study by the Société Française d'Oncologie Pédiatrique. Eur J Cancer (2002) 0.96
Will high dose chemotherapy followed by autologous bone marrow transplantation supplant cranio-spinal irradiation in young children treated for medulloblastoma? J Neurooncol (1996) 0.96
Potent therapeutic activity of irinotecan (CPT-11) and its schedule dependency in medulloblastoma xenografts in nude mice. Int J Cancer (1997) 0.96
Dose-dependent neurotoxicity of high-dose busulfan in children: a clinical and pharmacological study. Cancer Res (1990) 0.96
Long-term follow up of 69 patients treated for optic pathway tumours before the chemotherapy era. Arch Dis Child (1998) 0.95
Prognostic factors in pediatric spinal cord astrocytoma. Cancer (1998) 0.95
Ifosfamide and etoposide in childhood osteosarcoma. A phase II study of the French Society of Paediatric Oncology. Eur J Cancer (1997) 0.95
The radiological appearances of telangiectatic osteosarcoma. A study of 14 cases. Skeletal Radiol (1987) 0.95
High-grade glioma in children under 5 years of age: a chemotherapy only approach with the BBSFOP protocol. Eur J Cancer (2006) 0.94
The role of radiation therapy in the management of craniopharyngioma: a 25-year experience and review of the literature. Int J Radiat Oncol Biol Phys (1999) 0.94
Hypercalcemia preferentially occurs in unusual forms of childhood non-Hodgkin's lymphoma, rhabdomyosarcoma, and Wilms' tumor. A study of 11 cases. Cancer (1984) 0.94
[Neurofibromatosis 1: recommendations for management]. Arch Pediatr (2002) 0.94
Potentiation of radiation therapy by the oncolytic adenovirus dl1520 (ONYX-015) in human malignant glioma xenografts. Br J Cancer (2003) 0.94
Outcome of children treated with preradiation chemotherapy for a high-grade glioma: results of a French Society of Pediatric Oncology (SFOP) Pilot Study. Pediatr Blood Cancer (2007) 0.92
Radiation therapy in the management of craniopharyngioma: current concepts and future developments. J Pediatr Endocrinol Metab (2006) 0.92
[Li-Fraumeni syndrome: update, new data and guidelines for clinical management]. Bull Cancer (2001) 0.92
Childhood craniopharyngioma: hypothalamus-sparing surgery decreases the risk of obesity. J Clin Endocrinol Metab (2013) 0.92
Pharmacodynamics of tandem high-dose melphalan with peripheral blood stem cell transplantation in children with neuroblastoma and medulloblastoma. Bone Marrow Transplant (2001) 0.91
Results of the LMT81 protocol, a modified LSA2L2 protocol with high dose methotrexate, on 84 children with non-B-cell (lymphoblastic) lymphoma. Med Pediatr Oncol (1992) 0.91
Epileptic syndromes, cognitive assessment and school placement: a study of 251 children. Dev Med Child Neurol (2000) 0.91
Benefit of intravenous immunoglobulin in autoimmune stiff-person syndrome in a child. J Pediatr (2001) 0.91
Endocrine aspects and tumoral markers in intracranial germinoma: an attempt to delineate the diagnostic procedure in 14 patients. J Pediatr (1982) 0.90
Temozolomide in paediatric high-grade glioma: a key for combination therapy? Br J Cancer (2004) 0.90
Treatment of stage IV-S neuroblastoma: a study of 34 cases treated between 1982 and 1987. Med Pediatr Oncol (1991) 0.89
Chemotherapy of metastatic and/or recurrent undifferentiated nasopharyngeal carcinoma with cisplatin, bleomycin, and fluorouracil. J Clin Oncol (1991) 0.89
Genetic alterations in primary osteosarcoma from 54 children and adolescents by targeted allelotyping. Br J Cancer (2003) 0.88
[An uncommon site of malignant germ cell tumor secreting alpha fetoprotein: the posterior mediastinum]. Arch Fr Pediatr (1993) 0.87
Treatment of advanced neuroblastoma with high-dose melphalan and autologous bone marrow transplantation. Cancer Chemother Pharmacol (1986) 0.87
Streptococcal septicaemia following autologous bone marrow transplantation in children treated with high-dose chemotherapy. Bone Marrow Transplant (1991) 0.87
[Neurofibromatosis 1: recommendations for management]. Ann Dermatol Venereol (2001) 0.87
Supratentorial embryonal tumors in children under 5 years of age: an SFOP study of treatment with postoperative chemotherapy alone. Med Pediatr Oncol (2002) 0.87
Neuropsychological outcome in children with optic pathway tumours when first-line treatment is chemotherapy. Br J Cancer (2003) 0.86
High-dose busulfan and cyclophosphamide with autologous bone marrow transplantation support in advanced malignancies in children: a phase II study. J Clin Oncol (1986) 0.86
Chemotherapy for unresectable and recurrent intramedullary glial tumours in children. Brain Tumours Subcommittee of the French Society of Paediatric Oncology (SFOP). Br J Cancer (1999) 0.86
X linked spastic paraplegia (SPG2): clinical heterogeneity at a single gene locus. J Med Genet (1993) 0.85
Carboplatin and VP 16 in medulloblastoma: a phase II Study of the French Society of Pediatric Oncology (SFOP). Med Pediatr Oncol (1994) 0.85
Cloning and expression of the pea gene encoding SBP65, a seed-specific biotinylated protein. Plant Mol Biol (1997) 0.85
Management of osteogenic sarcoma in children and adolescents. Clin Orthop Relat Res (1991) 0.85
In children and adolescents, the pharmacodynamics of high-dose busulfan is dependent on the second alkylating agent used in the combined regimen (melphalan or thiotepa). Bone Marrow Transplant (2003) 0.85
Chemotherapy in osteogenic sarcoma: the experience of the Pediatric Department of the Gustave Roussy Institute. Cancer Treat Res (1993) 0.84
Carcinoma of the choroid plexus: a pediatric experience. Med Pediatr Oncol (1993) 0.83
[Epilepsy surgery in France]. Neurochirurgie (2008) 0.82
Primitive cerebral neuroectodermal tumors excluding medulloblastomas: a retrospective study of 30 cases. Pediatr Neurosurg (1998) 0.82
High-dose busulfan and thiotepa followed by autologous stem cell transplantation (ASCT) in previously irradiated medulloblastoma patients: high toxicity and lack of efficacy. Bone Marrow Transplant (2005) 0.82
Selection of spirometric measurements in a clinical trial, the Lung Health Study. Am J Respir Crit Care Med (1995) 0.82
Phase II study of ifosfamide in childhood brain tumors: a report by the French Society of Pediatric Oncology (SFOP). Med Pediatr Oncol (1993) 0.82
[Modern technics of irradiation of brain tumors in children]. Bull Cancer (1990) 0.82
[Congenital tuberculosis: difficulties in early diagnosis]. Arch Pediatr (1999) 0.82
An attempt to treat pediatric intracranial alphaFP and betaHCG secreting germ cell tumors with chemotherapy alone. SFOP experience with 18 cases. Société Française d'Oncologie Pédiatrique. J Neurooncol (1998) 0.82
Vermian agenesis without posterior fossa cyst. Pediatr Radiol (1994) 0.82
[Post-radiotherapy hyperthyroidism: a rare complication of cancer treatment in the child]. Arch Pediatr (2003) 0.81
[Medulloblastomas: review]. Rev Neurol (Paris) (2011) 0.81
Phase II study of high-dose thiotepa and hematopoietic stem cell transplantation in children with solid tumors. Bone Marrow Transplant (1998) 0.81
Necrotising leukoencephalopathy complicating treatment of childhood leukaemia. J Neurol Neurosurg Psychiatry (1984) 0.81